Investigation the Ability to Produce Induced Pluripotent Cells from Human Pancreatic Cancer Xenografts
Background and Aim: There is increasing evidence that cancer cells in addition to multiple genetic mutations, also acquire epigenetic abnormalities during development, maintenance, and progression. By utilizing the reprogramming technology as a tool to introduce the ‘pressure’ to alter epigenetic re...
Main Authors: | Reyhaneh Khoshchehreh, Mehdi Totonchi, Hossein Baharvand, Marzieh Ebrahimi |
---|---|
Format: | Article |
Language: | fas |
Published: |
Arak Medical University
2019-08-01
|
Series: | Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Arāk |
Subjects: | |
Online Access: | http://jams.arakmu.ac.ir/article-1-5973-en.html |
Similar Items
-
Establishment and Characterisation by Expression Microarray of Patient-Derived Xenograft Panel of Human Pancreatic Adenocarcinoma Patients
by: Sandra Roche, et al.
Published: (2020-01-01) -
Establishing and Maintaining an Extensive Library of Patient-Derived Xenograft Models
by: Marissa Mattar, et al.
Published: (2018-02-01) -
Assessment of Hypoxia in the Stroma of Patient-Derived Pancreatic Tumor Xenografts
by: Ines Lohse, et al.
Published: (2014-02-01) -
Patient-Derived Xenograft Models in Urological Malignancies: Urothelial Cell Carcinoma and Renal Cell Carcinoma
by: Andrew T. Tracey, et al.
Published: (2020-02-01) -
Enhancing efficacy of gemcitabine in pancreatic patient-derived xenograft mouse models
by: Andriana Inkoom, et al.
Published: (2020-12-01)